Pfizer Issues Voluntary Nationwide Recall for Lots of Quinapril HCI Due to N-Nitroso-Quinapril Content
Pfizer voluntarily recalled 5 lots of quinapril HCI (Accupril) tablets distributed to the patient level as a result of the presence of the N-nitroso-quinapril nitrosamine, observed in recent testing over the acceptable daily intake (ADI) level. Pfizer recalls Accupril According to Pfizer press release, nitrosamines are common in water and numerous foods, such as cured […]




